News
$Syndax Pharmaceuticals (SNDX.US)$ Reuters· just
FDA Approves Revumenib for Relapsed or Refractory Acute Leukemia With a Kmt2a Translocation
FDA Approves Revumenib for Relapsed or Refractory Acute Leukemia With a Kmt2a Translocation
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Daily Investors : You ever check the Bio Tech website for the dates, times of any possible explosion
Trytosaveabit OP Daily Investors : If you’re asking if I keep up with FDA PDUFA calendar and such! Yes! I actually make a lot of reminder posts to followers saying ( PDUFA date on such and such )